Author

R. C. Arduino

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 2

Frequent Co-Authors

A. Grattoni· 2 shared C. Y. X. Chua· 2 shared F. P. Pons-Faudoa· 2 shared J. E. Nichols· 2 shared J. T. Kimata· 2 shared K. A. Shelton· 2 shared L. R. Bushman· 2 shared P. L. Anderson· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Grattoni

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintDec 15, 2022

Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates

F. P. Pons-Faudoa, N. Di Trani, S. Capuani…·A. Grattoni

An ultra-long-acting refillable nanofluidic implant sustained islatravir levels in non-human primates for 20 months and provided 100% protection against SHIV infection.

DOI 10.1101/2022.12.15.520646

non-human primateexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivMay 13, 2020

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

F. P. Pons-Faudoa, A. Sizovs, K. A. Shelton…·A. Grattoni

This study evaluates a long-acting tenofovir alafenamide nanofluidic implant in nonhuman primates, showing partial protection against SHIV infection.

DOI 10.1002/adtp.202000163

non-human primateexperimental assay

𝕏 PostBluesky